Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 15576 - 15600 of 15711 in total

(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol

Experimental

[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE

Experimental

N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide

Experimental

5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole

5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. Known drug targets of 5-(3-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)propyl)-3-methyl isoxazole include genome polyprotein.
Experimental

BMS-903452

BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational

Dapaconazole

Dapaconazole has been used in trials studying the treatment of Tinea Pedis.
Investigational

Azeliragon

Azeliragon has been used in trials studying the treatment of Alzheimer's Disease.
Investigational

Ritanserin

Ritanserin has been used in trials studying the treatment of Cocaine-Related Disorders.
Investigational

2,2-bis(4-hydroxy-3-tert-butylphenyl)propane

TBD has been used in trials studying the treatment of Adenocarcinoma.
Investigational

Viminol

Experimental

Budipine

Experimental

Levomethadone

Experimental

Sequifenadine

Experimental

Picloxydine

Experimental

Xibornol

Experimental

Guanoclor

Experimental

3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE

Experimental

6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one

Experimental

ATX-201

ATX-201 is one of a family of novel compounds that inhibits microtubule polymerization. It is developed by Kythera Biopharmaceuticals, Inc. for the treatment of actinic keratosis. The company announced the decision to discontinue its ATX-201 clinical program for actinic keratosis. The Company determined that the program was not meeting their...
Investigational
Matched Description: … The Company determined that the program was not meeting their expected primary and exploratory objectives …

2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL

Experimental

4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE

Experimental

NV-18

NV-18 is a product of the Novogen diphenolic synthetic analogue program that is creating drugs with diverse activities against specific types of cancer. Like phenoxodiol, NV-18 is broadly effective in the laboratory against almost all human cancer types, but NV-18 is distinctive in showing particular potency against melanoma and cholangiocarcinoma...
Investigational
Matched Description: … almost all human cancer types, but NV-18 is distinctive in showing particular potency against melanoma and …

Sirna-027

Sirna-027 is a chemically modified short interfering RNA(siRNA) targeting Vascular Endothelial Growth Factor Receptor-1(VEGFR-1). VEGFR-1 is a key component of the clinically validated vascular endothelial growth factor (VEGF) pathway. Sirna-027 is developed by Sirna Therapeutics and is under the phase I of clinical trails. It is used to treat Macular...
Investigational
Matched Description: … Sirna-027 is developed by Sirna Therapeutics and is under the phase I of clinical trails. …

2,5-Dimethoxy-4-(n)-propylthiophenethylamine

Experimental
Illicit

R048-8071

Experimental
Displaying drugs 15576 - 15600 of 15711 in total